WHO Expert Committee on Specifications for Pharmaceutical Preparations fortieth report.

This report presents the recommendations of an international group of experts convened by the World Health Organization to consider matters concerning the quality assurance of pharmaceuticals and specifications for drug substances and dosage forms. Annexes include: a list of available international...

Full description

Saved in:
Bibliographic Details
Corporate Authors: World Health Organization, WHO Expert Committee on Specifications for Pharmaceutical Preparations, ebrary, Inc
Format: Electronic eBook
Language:English
Published: Geneva : World Health Organization, 2006.
Series:Technical report series (World Health Organization) ; 937.
Subjects:
Online Access:An electronic book accessible through the World Wide Web; click to view
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000Ia 4500
001 0000085759
005 20171002054338.0
006 m u
007 cr cn|||||||||
008 060721s2006 sz a sb i100 0 eng d
020 |z 9241209372 
035 |a (CaPaEBR)ebr10137826 
035 |a (OCoLC)70830413 
040 |a CaPaEBR  |c CaPaEBR 
050 1 4 |a RA8  |b .A247 2006eb 
245 0 0 |a WHO Expert Committee on Specifications for Pharmaceutical Preparations  |h [electronic resource] :  |b fortieth report. 
260 |a Geneva :  |b World Health Organization,  |c 2006. 
300 |a x, 461 p. :  |b ill. 
490 1 |a WHO technical report series ;  |v 937 
500 |a "WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 24-28 October 2005"--P. vii. 
504 |a Includes bibliographical references. 
520 |a This report presents the recommendations of an international group of experts convened by the World Health Organization to consider matters concerning the quality assurance of pharmaceuticals and specifications for drug substances and dosage forms. Annexes include: a list of available international chemical reference substances and international infrared spectra; supplementary guidelines on good manufacturing practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical dosage forms; updated supplementary guidelines on good manufacturing practices for the manufacture of herbal medicines; supplementary guidelines on good manufacturing practices for validation; good distribution practices for pharmaceutical products; a model quality assurance system for procurement agencies (recommendations for quality assurance systems focusing on prequalification of products and manufacturers, purchasing, storage and distribution of pharmaceutical products); multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability; a proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms; and additional guidance for organizations performing in vivo bioequivalence studies. 
533 |a Electronic reproduction.  |b Palo Alto, Calif. :  |c ebrary,  |d 2009.  |n Available via World Wide Web.  |n Access may be limited to ebrary affiliated libraries. 
650 0 |a Drugs  |x Standards  |v Congresses. 
650 0 |a Pharmacopoeias  |v Congresses. 
650 0 |a Drugs  |x Quality control  |v Congresses. 
655 7 |a Electronic books.  |2 local 
710 2 |a World Health Organization. 
710 2 |a WHO Expert Committee on Specifications for Pharmaceutical Preparations  |n (40th :  |d 2005 :  |c Geneva, Switzerland) 
710 2 |a ebrary, Inc. 
830 0 |a Technical report series (World Health Organization) ;  |v 937. 
856 4 0 |u http://site.ebrary.com/lib/daystar/Doc?id=10137826  |z An electronic book accessible through the World Wide Web; click to view 
908 |a 170314 
942 0 0 |c EB 
999 |c 74916  |d 74916